Optimization of Formulation Variables to Increase Antigen Entrapment in PLGA Particles

Polymer - Plastics Technology and Engineering

Volumn 51, Issue 14, 2012, Pages 1468-1473

  Fredriksen, Børge N ^a   Hølvold, Linn Benjaminsen ^a   Bøgwald, Jarl ^a   Dalmo, Roy A ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Antigen entrapment; Optimization; Organic solvent; PGLA; PVA

Indexed keywords

AQUEOUS PHASE; BOVINE SERUM ALBUMINS; DOUBLE EMULSION-SOLVENT EVAPORATION; ENCAPSULATION EFFICIENCY; ENTRAPMENT EFFICIENCY; ETHYL ACETATES; KEY FACTORS; PGLA; PHASE RATIOS; POLY LACTIDE-CO-GLYCOLIDE; PRODUCTION YIELD; PVA; SHORT SUPPLY;

COPOLYMERS; DICHLOROMETHANE; EMULSIFICATION; ENCAPSULATION; IODINE; ISOTOPES; OPTIMIZATION; ORGANIC SOLVENTS;

ANTIGENS;

EID: 84868265705     PISSN: 03602559     EISSN: 15256111     Source Type: Journal    
DOI: 10.1080/03602559.2012.715358     Document Type: Article

References (42)

1. Ogawa, Y.; Yamamoto, M.; Okada, H.; Yashiki, T.; Shimamoto, T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic glycolic) acid. Chem. Pharma Bull. 1988, 36, 1095.
2. Demento, S.L.; Eisenbarth, S.C.; Foellmer, H.G.; Platt, C.; Caplan, M.J.; Saltzman, W.M.; Mellman, I.; Ledizet, M.; Fikrig, E.; Flavell, R.A.; Fahmy, T.H. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 2009, 27, 3013.
3. Hamdy, S.; Elamanchili, P.; Alshamsan, A.; Molavi, O.; Satou, T.; Samuel, J.J. Enhanced antigen-specific primary CD4(+) and CD8(+) responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly (D,L-lactic-co-glycolic acid) nanoparticles. Biomed. Mater. Res. A 2007, 81A, 652.
4. Hamdy, S.; Molavi, O.; Ma, Z.S.; Haddadi, A.; Alshamsan, A.; Gobti, Z.; Elhasi, S.; Samuel, J.; Lavasanifar, A. Co-delivery of cancer-associated antigen and Toll-like receptor ligand in PLGA nanoparticles induces potent CD8(+) T cell-mediated anti-tumor immunity. Vaccine 2008, 26, 5046.
5. Schlosser, E.; Mueller, M.; Fischer, S.; Basta, S.; Busch, D.H.; Gander, B.; Groettrup, M. TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 2008, 26, 1626.
6. Tian, J.; Yu, J. Poly(lactic-co-glycolic acid) nanoparticles as candidate DNA vaccine carrier for oral immunization of Japanese flounder (Paralichthysolivaceus) against lymphocystis disease virus. Fish Shellfish Immun. 2011, 30, 109.
7. Nayak, B.; Panda, A.K.; Ray, P.; Ray, A.R. Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination. J. Microencapsul. 2009, 26, 154.
8. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliver. Rev. 2003, 55, 329.
9. Jain, R.A.The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials2000, 21, 2475.
10. Gupta, R.K.; Alroy, J.; Alonso, M.J.; Langer, R.; Siber, G.R. Cronic local tissue reactions, long term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers. Vaccine 1997, 15, 1716.
11. Panyam, J.; Dali, M.A.; Sahoo, S.K.; Ma, W.X.; Chakravarthi, S.S.; Amidon, G.L.; Levy, R.J.; Labhasetwar, V.J. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. Contr. Rel. 2003, 92, 173.
12. Semete, B.; Booysen, L.; Lemmer, Y.; Kalombo, L.; Katata, L.; Verschoor, J.; Swai, H.S. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery devices. Nanomed.-Nanotechnol. 2010, 6, 662.
13. Wang, J.; Wang, B.A.; Schwendeman, S.P.J. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres. Cont. Rel. 2002, 82, 289.
14. Scholes, P.D.; Coombes, A.G.A.; Illum, L.; Davis, S.S.; Vert, M.; Davies, M.C.J. The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site specific drug delivery. Contr. Rel. 1993, 25, 145.
15. Freitas, S.; Merkle, H.P.; Gander, B.J. Microencapsulation by solvetextraction/evaporation: reviewing the state of the art of microsphere preparation process technology. Contr. Rel. 2005, 102, 313.
16. Ulevitch, R.J. Preparation and characterization of a radioiodinatedbacterial lipopolysaccharide. Immunochemistry 1978, 15, 157.
17. Chong, C.S.W.; Cao, M.; Wong, W.W.; Fischer, K.P.; Addison, W.R.; Kwon, G.S.; Tyrrell, D.L.; Samuel, J.J. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. Cont. Rel. 2005, 102, 85.
18. Lutsiak, M.E.C.; Kwon, G.S.; Samuel, J.J. Biodegradable nanoparticle delivery of a Th2-biased paptide for induction of Th1 immune responses. Pharm. Pharmacol. 2006, 58, 739.
19. Sahana, D.K.; Mittal, G.; Bhardwaj, V.; Kumar, M.N.V.R.J. PLGA nanoparticles for oral delivery of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. Pharm. Sci. 2008, 97, 1530.
20. Shen, H.; Ackerman, A.L.; Cody, V.; Giodini, A.; Hinson, E.R.; Cresswell, P.; Edelson, R.L.; Saltzman, W.M.; Hanlon, D.J. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 2006, 117, 78.
21. Fredriksen, B.N.; Sævaried, K.; McAuley, L.; Lane, M.E.; Bøgwald, J.; Dalmo, R.A. Early immune responses in Atlantic salmon (Salmosalar L.) after immunization with PLGA nanoparticles loaded with a model antigen and β-glucan. Vaccine 2011, 29, 8338.
22. Fredriksen, B.N. J. PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmosalar L.). Grip. Vaccine 2012, 30, 656.
23. Raghuvanshi, R.S.; Singh, O.; Panda, A.K. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Drug Deliv. 2002, 9, 113.
24. Jeffery, H.; Davis, S.S.; Ohagan, D.T. The preparation and characterization of poly(lactide-co-glycolide) microparticles 2. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm. Res. 1993, 10, 362.
25. Lamprecht, A.; Ubrich, N.; Hombreiro Perez, M.; Lehr, C.-M.; Hoffman, M.; Maincent, P. Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification. Int. J. Pharm. 1999, 184, 97.
26. Lamprecht, A.; Ubrich, N.; Hombreiro Perez, M.; Lehr, C.-M.; Hoffman, M.; Maincent, P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int. J. Pharm. 2000, 196, 177.
27. Feczko, T.; Toth, J.; Dosa, Gy.; Gyenis, J. Optimization of protein encapsulation in PLGA nanoparticles. Chem. Eng. Proc. 2011, 50, 757.
28. Zhao, A.; Rodgers, V.G.J.J. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles. Cont. Rel. 2006, 113, 15.
29. Mattheolabakis, G.; Lagoumintzis, G.; Panagi, Z.; Papadimitriou, E.; Partidos, C.D.; Avgoustakis, K. Transcutaneous delivery of a nanencapsulated antigen: Induction of immune responses. Int. J. Pharm. 2010, 385, 187.
30. Chen, X.Q.; Yang, Y.-Y.; Wang, L.; Chung, T.-S. Effects of inner water volume on the peculiar surface morphology of microspheres fabricated by double emulsion technique. J. Microencapsul. 2001, 18, 637.
31. Sahoo, S.K.; Panyam, J.; Prabha, S.; Labhasetwar, V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Contr. Rel. 2002, 82, 105.
32. Sharif, S.; Ohagan, D.T. A comparison of alternative methods for the determination of the level of proteins entrapped in poly(lactide-co-glycolide) microparticles. Int. J. Pharm. 1995, 115, 259.
33. Kofler, N.; Ruedl, C.; Klima, J.; Recheis, H.; Bock, G.; Wick, G.; Wolf, H.J. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotrophic bacterial antigens. Immunol. Meth. 1996, 192, 25.
34. Panyam, J.; Sahoo, S.K.; Prabha, S.; Bargar, T.; Labhasetwar, V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. Int. J. Pharm. 2003, 262, 1.
35. Yushu, H.; Venkatraman, S.J. The effect of process variables on the morphology and release and characterization of protein-loaded PLGA particles. Appl. Polym. Sci. 2006, 101, 3053.
36. Birnbaum, D.T.; Kosmala, J.D.; Henthorn, D.B.; Brannon-Peppas, L.J. Controlled release of beta-estradiol from PLAGA microparticles: The effect of organic phase solvent on encapsulation and release. Contr. Rel. 2000, 65, 375.
37. Bodmeier, R.; Mcginity, J.W. Solvent selection in the preparation of poly(D,L-lactide) microspheres prepared by the solvent evaporation method. Int. J. Pharm. 1988, 43, 179.
38. Cho, M.; Sah, H. Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process. J. Microencapsul. 2005, 22, 1.
39. Sneh-Edri, H.; Likhtenshtein, D.; Stepensky, D. Intracellular targeting of PLGA nanoparticles encapsulating antigenic peptide to the endoplasmic reticulum of dendritic cells and its effect on antigen cross-presentation in vitro. Mol. Pharm. 2011, 8, 1266.
40. Slutter, B.; Plapied, L.; Fievez, V.; Sande, M.A.; Rieux, A.D.; Schneider, Y.-J.; Riet, E.V.; Jiskoot, W.; Preat, V.J. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. Contr. Rel. 2009, 138, 113.
41. Trombone, A.P.F.; Silva, C.L.; Almeida, L.P.; Rosada, R.S.; Lima, K.M.; Oliver, C.; Jamur, M.C.; Coelho-Castelo, A.A.M. Tissue distribution of DNA-Hsp65/TDM-loaded PLGA microspheres and uptake by phagocytic cells. Genet. Vacc. Ther. 2007, 20 (5), 9.
42. Cruz, L.J.; Tacken, P.J.; Bonetto, F.; Buschow, S.J.; Croes, H.J.; Wijers, M.; Jolanda de Vries, I.; Fidgor, C.G. Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. Mol. Pharm. 2011, 8, 520.